siRNA labeled with AlexaFluor 555 targeting 3'-UTR which allowed FMNL2 wild type (FMNL2-GFP) or mutant (FMNL2-S1072E-GFP) DNA expression in the same cell.
Error bar, ± SEM of 9 (FMNL2-S1072E-GFP) and 11 (FMNL2-GFP) cells respectively. 
Supplemental Experimental Procedures Plasmids
Expression plasmids were generated and sequence-verified following standard cloning procedures. FLAG-FMNL2, FLAG-FMNL2-F1F2-CT, FLAG-mDia1 and HA-RhoCV14 were described previously (Kitzing et al., 2010; Vaillant et al., 2008) . myc-FMNL2, FMNL2-myc, and myc-FMNL2-FH3 (aa 262-484) were sub-cloned into EFpLink with N-terminal or C-terminal myc-tag as indicated. GST-FMNL2-959-CT for protein purification was cloned into pGEX-6P-1 (GE Healthcare). HA-FMNL2-NT (aa 23-484) was cloned as GST-HA-FMNL2-NT into pGEX-6P-1, and the GST tag was cleaved during purification. His-FMNL2-NT was cloned into pET20 (Novagen) and His-FMNL2-FH2-CT was cloned into pET30 (Novagen). FMNL2 was cloned into pmCherryN1 (Clonetech), pEGFPN1 (Clonetech) or pWPXL vectors. Point mutants FMNL2-S1072A, S1072E and ILI3A (I704A, L1028A, and I1029A) were generated by site-directed point mutation. α5-integrin-GFP, GFP-PKCα and GFP-PKCα-T497A were described (Mostafavi-Pour et al., 2003) . GFP-PKCα-CA was generated by deleting the first 30 amino acids (Soh and Weinstein, 2003) and subcloned into pEGFPC1 vector (Clonetech).
Cell Lines, Drug Treatments and Transfection
HEK293, HEK293T, HeLa and A375M2 (kind gift from Eric Sahai) cells were maintained in DMEM supplemented with 10% fetal bovine serum at 37°C in a 5% CO 2 environment. When needed, cells were treated with 5 nM to 200 nM TPA (Calbiochem), 2 µM BIM-1 (Calbiochem), 1 µM Gö6976 (Calbiochem) or 8 µM A23187 (Sigma). DNA plasmids were transfected with calcium phosphate methods for HEK293 and HEK293T cells, and with Fugene (Promega) for HeLa cells. siRNA (Qiagen) was transfected with HiperFect (Qiagen). A375M2 stable cell lines were generated by lentiviral transduction.
Viruses were produced by transfecting HEK293T cells with packaging plasmid pSPAX2, envelope plasmid pMD2G and expressing plasmids pWPXL-GFP, -FMNL2-GFP, -FMNL2-S1072A-GFP, -FMNL2-S1072E-GFP, or -FMNL2-ILI3A-GFP. Supernatants were harvested 48 h after transfection and A375M2 cells were infected. HeLa stable cell lines expressing shFMNL2 (V2LHS_384851, Open Biosystems) or shControl (a kind gift by Thorsten Stiewe) were generated similarly with lentiviral shRNAs.
Reagents and Antibodies
Cell culture reagents were purchased from PAA/GE Healthcare. Chemicals were from
Sigma. α-phospho-(Ser) PKC substrate, α-PKCα, α-PKCδ, α-PKCε, α-PKCζ, α-biotin-HRP and α-tubulin were obtained from Cell Signaling Technology. α-PKCβ was from Santa Cruz. α-FMNL2 was purchased from Atlas Antibodies. α-α5 integrin (CD49e) was from AbD serotec. α-β1 integrin (CD29) antibody K20 was purchased from Beckman Coulter, 610468 was from BD Biosciences, 12G10 and EP1041Y were from
Abcam. α-α2 integrin (MAB1998Z) was from Millipore. α-TfR (ab84036) was from
Abcam. α-HRP-conjugated FLAG, myc and HA antibodies and HRP-conjugated secondary antibodies were from Sigma. Alexa Fluor conjugated secondary antibodies were from Invitrogen.
DNA Primers and siRNA Sequences
Point mutants FMNL2-S1072A, S1072E and ILI3A (I704A, L1028A, and I1029A) were generated by site-directed point mutation using the following primer pairs: respectively. The actin assembly deficient mutant was generated according to (Heimsath and Higgs, 2012; Thompson et al., 2013) . siRNA targeting sequences were:
5'-CACCATGGCTGCAATCCGAAA-3' (human RhoC), 
Screening for the Effects of Formins on β1-integrin Endocytosis by Cell Spot Microarray
Cell Spot Microarrays (CSMA) were conducted as previously described (Rantala et al., 2011) . Formin targeting siRNAs Hs_C14orf173_2 and 5 (INF2), Hs_DAAM1_6 and 7, Hs_DAAM2_7 and 8, Hs_DIAPH1_2 and 4, Hs_DIAPH2_1 and 4, Hs_DIAPH3_8 and 9, Hs_FHOD1_6 and 7, Hs_FHOD3_6 and 7, Hs_FMN1_7 and 8, Hs_FMN2_11 and 12, Hs_FMNL1_8 and 9, Hs_FMNL2_8 and 9, Hs_FMNL3_6 and 7, Hs_GRID2IP_5 and 6 (Delphilin), and control siRNA were purchased from Qiagen. Before plating HeLa cells on CSMA, the arrays where blocked with Lutrol F108 (Univar AB) for 15 min at room temperature. Cells were washed and harvested using HyQTase, then plated on CSMA.
Endocytosis was measured 72 h after the reverse siRNA transfection. Antibody based integrin β1 endocytosis assay was carried out as described (Arjonen et al., 2012) . In short, non-functional blocking β1-integrin antibody (K20) was labeled using AlexaFluor 488 protein labelling kit (Invitrogen). Cell surface β1-integrins of the CSMA with live cells were labeled with K20-AlexaFluor 488 for 1 h on ice. CSMA was then washed and the labeled β1-integrin was allowed to be endocytosed for 30 min at 37°C. The residual cell surface fluorescence was quenched using anti-AlexaFluor 488 antibody (Invitrogen) for 1 h on ice and fixed using 4% paraformaldehyde. Cells were then permeabilized and incubated with anti-mouse AlexaFluor 555 secondary antibody to label both internal and cell surface K20 pools (total β1-integrin). Endocytosed β1-integrin was normalized against the total β1 integrin. Nuclei were labeled using Syto60 (Invitrogen). Fluorescence intensities were measured using Laser microarray scanner (Tecan LS400) and ArrayPro Analyzer v4.5 software.
Protein Purification
The expression plasmid was transformed into E. coli BL21 (DE3). Bacteria were cultured in LB medium at 37°C until OD = 0.6 and induced with 200 µM IPTG at 22°C for 16 h or 12.5 g/L lactose at 30°C for 16 h. GST fusion protein was purified using Glutathione Sepharose 4B beads (GE Healthcare) as described before (Brandt et al., 2009 ). Proteins were dialyzed in 20 mM Hepes (pH 7.4), 25 mM MgCl 2 , 5 mM EDTA and 5 mM DTT.
The GST tag was cleaved during dialysis using Precision Protease (GE Healthcare) when necessary and the cleaved protein was recycled by running through the Glutathione Sepharose 4B once more. 6×His fusion protein was purified using Ni-NTA agarose beads (Qiagen) as shown before (Brandt et al., 2007) .
In vitro Kinase Assay
Purified recombinant GST fusion PKC protein isozymes were purchased from ProQinase
GmbH. 20 ng of each PKC isozyme and 1 µg substrate protein were incubated in 50 mM Hepes (pH 7.4), 150 mM NaCl, 5 mM EDTA, 5 mM DTT, 25 mM MgCl 2 , 0.02% Triton X-100, 1 mM ATP and 5 µCi 32 P-γ-ATP at 30°C for 15 min. 1 µM Staurosporine (Sigma) was used when indicated. Kinase reaction was stopped by adding the SDS sample buffer.
After running SDS-PAGE and fixation of the gel, autoradiography was performed with different exposure times.
Internalization Assay
Integrin or transferrin receptor (TfR) internalization assays were performed as described (Pellinen et al., 2008) . 24 h after seeding, cell surfaces were labeled for 30 min with 0.5 mg/mL EZ-Link Sulfo-NHS-SS-Biotin (Pierce Chemical). Internalization was followed for the indicated times. The residual biotin was then removed from the cell surface by MesNa reduction (60 mM, 30 min), followed by iodoacetamide quenching (100 mM, 15 min). Total proteins were immunoprecipitated using the integrin or TfR antibodies.
Internalized proteins were detected using Western blot with the HRP-linked biotin antibody. Total proteins were detected by integrin or TfR antibodies. Student's T-test was used to calculate the p-values.
Immunoprecipitation and Biotin-Streptavidin Pull-down
Cells were harvested and lysed in lysis buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate, and complete protease inhibitors (Roche). Supernatants were collected after centrifugation and incubated with FLAG/myc/HA-conjugated agarose beads (Sigma) or Protein A/G beads (Santa Cruz)
together with antibodies for 1 to 5 h at 4°C. For pull-downs, biotinylated α5/β1-integrin cytoplasmic tail peptides were pre-incubated with cell lysates respectively for 4 h (Pellinen et al., 2008) . The peptide sequences were: α5-integrin cytoplasmic tail:
Biotin-YKLGFFKRSLPYGTAMEKAQLKPPATSDA; β1-integrin cytoplasmic tail:
Biotin-HDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK; α-integrin conserved cytoplasmic tail: Biotin-WKLGFFKRKYEKM. Following a 1 h incubation with Streptavidin sepharose beads (GE Healthcare), samples were washed. Western blotting were performed as described previously (Brandt et al., 2009 ).
Membrane Flotation Assay
Membrane flotation assays were performed as described (Pan et al., 2012) . Cells were lysed in cold TNE buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, protease inhibitors and phosphatase inhibitors) and passed through 25G syringe 20 times.
After centrifugation, supernatants were mixed with 67% Optiprep (Invitrogen) and loaded to SW60 centrifuge tubes. Each sample was overlaid with 2.5 mL 28% Optiprep and 600 µL TNE buffer. Ultracentrifugation was performed with SW60 rotor at 35,000 rpm for 3 h at 4°C (Beckman Coulter). 500 µL fractions were collected with the 2nd and 8th as the membrane and soluble fractions respectively.
Imaging-based Integrin Endocytosis Assay
HeLa cells were transfected with Qiagen Hs_FMNL2_9 siRNA (targeting 3'UTR) and EGFP or different FMNL2-GFP plasmids. Endocytosis was carried out as described with modifications (Gu et al., 2011) . Cell surface β1-integrins were stained with primary and secondary antibodies for 1 h on ice and cells were allowed to endocytose the labeled 
Inverted Transwell Invasion Assay and Image Analysis
Invasion assays were performed as described (Kitzing et al., 2010) . Cells were transfected with siRNAs 48 h before analysis. Cells were invading for 48 h before fixation, permeabilization and subsequent staining with DAPI and rhodamine phalloidin (Invitrogen). Confocal z-stacks of 100 µm were acquired for five random imaging fields of each insert with LSM 700 confocal microscope (Zeiss), using the 20X/0.75 objective.
Quantification of the invaded and non-invaded cell number was done using the ImageJ Analyze Particle function. Student's T-test was used to calculate the p-values.
Expression of Cell Surface Integrins
HeLa cells were silenced 72h. Cells were harvested using HyQTase (Fisher Scientific) spinned down, lifted on ice and washed with ice-cold PBS. Cells were blocked using 2%
BSA in PBS for 30min at 4°C and stained against α2, α5 and β1-integrins. Cells were washed in PBS and counterstained using Alexa-647 secondary antibodies for 30min at 4°C. Cells were washed in PBS and analysed with Accuri FACS.
MAL/SRF Luciferase Assay
MAL/SRF luciferase assay was performed as described (Baarlink et al., 2013) . HEK293 cells were transfected with genes of interests, p3DA.luc and pRLTK reporter plasmids.
24 h after transfection, cell media were removed and cells were washed once with PBS.
200 µL 1× Passive lysis buffer (Promega) was added per 6-well. Cells were lysed on ice for 20 min, scraped and centrifuged at 13,000 rpm for 15 min at 4°C. From 5 to 20 µL cell lysates were used for each assay. Firefly and Renilla luciferase signals were recorded sequentially by Luminoscan Ascent Microplate Luminometer (Thermo Scientific) using the Ascent software (Thermo Scientific) with 900 ms integration time. Firefly signal was normalized to Renilla signal for each sample.
